RFC
ALPN

Russell Frank Company’s Alpine Immune Sciences Inc ALPN Stock Holding History

Russell Frank Company’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$134K Buy
8,036
+4,784
+147% +$95.8K ﹤0.01% 2751
2015
Q4 		$105K Buy
+3,252
New +$111K ﹤0.01% 2798

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Russell Frank Company's ALPN Position: Q1 2016 in Review

Russell Frank Company increased its Alpine Immune Sciences Inc (ALPN) stake by 147% in Q1 2016, buying an estimated $95.8K and bringing the position to 8,036 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

Russell Frank Company first reported a position in ALPN in Q4 2015 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold ALPN as of Q1 2016.

  • Russell Frank Company held 8,036 shares of Alpine Immune Sciences Inc worth $134K as of Q1 2016.
  • Russell Frank Company bought 4,784 Alpine Immune Sciences Inc shares in Q1 2016, an estimated $95.8K.
  • Alpine Immune Sciences Inc made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2751 holding.
  • Russell Frank Company first reported a position in Alpine Immune Sciences Inc in Q4 2015 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.